1240494-13-6

Basic information

• Product Name: 2-[5-(4-fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic acid
• Synonyms: 2-[5-(4-fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic acid
• CAS NO: 1240494-13-6
• Molecular Weight: 382.223
• Mol File: 1240494-13-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-[5-(4-fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[5-(4-fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic acid(1240494-13-6)
• EPA Substance Registry System: 2-[5-(4-fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic acid(1240494-13-6)

Safety Data

• Hazardous Substances Data: 1240494-13-6(Hazardous Substances Data)

Usage

Potential Applications

Organic synthesis
Medicinal chemistry
Material science

Functions

Building block in organic compound synthesis
Ligand in catalytic reactions

Reactivity

Requires further research and experimentation for comprehensive understanding of properties and applications.

Upstream product

• 91983-14-1 2-bromomethylphenylboronic acid 
• 371-40-4 4-fluoroaniline 
• 17624-07-6 6-Mercapto-nicotinic acid 

Downstream Products

• 1240494-24-9 N-(4-fluorophenyl)-6-(2-hydroxybenzylthio)nicotinamide 

Relevant articles and documents

PYRIDINE- AND PYRIMIDINECARBOXAMIDES AS CXCR2 MODULATORS

There is disclosed pyridine-and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine-and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders.

Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators

There is disclosed pyridine- and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine- and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders.